Latest News about CRSP
Recent news which mentions CRSP
Why Are Gene-Editing Stocks CRSP, EDIT, NTLA Stock Up Today?
April 13, 2023
From InvestorPlace
CRISPR Therapeutics Is an Interesting 'Gene Editing Play for 2023' With Significant Upside, Says Analyst
April 13, 2023
Tickers
CRSP
From Benzinga
$2M Price Tag for Sickle Cell Gene Therapies Could Be Cost-Effective Under Certain Scenarios, Finds ICER Analysis
April 13, 2023
From Benzinga
From Benzinga
Consolidated Communications, CRISPR Therapeutics And Other Big Stocks Moving Higher On Thursday
April 13, 2023
From Benzinga
2 Nasdaq Growth Stocks That Are Screaming Buys in April
April 13, 2023
From Motley Fool
These Up-and-Coming Stocks Are Screaming Buys Right Now
April 13, 2023
From Motley Fool
Could This Move Make Vertex's Next Blockbuster Even Bigger?
April 12, 2023
From Motley Fool
From Benzinga
CRISPR Stock: Bull vs. Bear
April 08, 2023
From Motley Fool
From Motley Fool
Better Gene-Editing Stock: Editas Medicine vs. Bluebird Bio
April 06, 2023
From Motley Fool
From Benzinga
2 Under-the-Radar Biotech Stocks to Buy in 2023
April 05, 2023
From Motley Fool
From Motley Fool
The 10 Best Stocks to Buy in April 2023
April 01, 2023
From Motley Fool
From Motley Fool
5 Bargain-Basement Stocks to Buy Right Now
March 31, 2023
From Motley Fool
The 3 Best Growth Stocks to Buy in the Biotech Sector
March 29, 2023
From InvestorPlace
From InvestorPlace
Why Bluebird Bio Shares Are Plunging Today
March 29, 2023
From Benzinga
Could CRISPR Therapeutics Become the Next Moderna?
March 27, 2023
From Motley Fool
The 3 Best CRISPR Stocks to Buy Now Before They Skyrocket
March 25, 2023
From InvestorPlace
From Motley Fool
Tickers
CRSP
From Motley Fool
Thinking of Buying Biotech Stocks? Do These 3 Things First
March 22, 2023
From Motley Fool
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.